These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2327400

  • 21. Chelation of aluminium by combining DFO and L1 in rats.
    Blanusa M, Prester L, Varnai VM, Pavlović D, Kostial K, Jones MM, Singh PK.
    Toxicology; 2000 Jul 05; 147(3):151-6. PubMed ID: 10924797
    [Abstract] [Full Text] [Related]

  • 22. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D, Ponka P, Baker E.
    Cancer Res; 1994 Feb 01; 54(3):685-9. PubMed ID: 8306330
    [Abstract] [Full Text] [Related]

  • 23. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.
    Glickstein H, El RB, Shvartsman M, Cabantchik ZI.
    Blood; 2005 Nov 01; 106(9):3242-50. PubMed ID: 16020512
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Iron chelators induce apoptosis in proliferating cells.
    Hileti D, Panayiotidis P, Hoffbrand AV.
    Br J Haematol; 1995 Jan 01; 89(1):181-7. PubMed ID: 7833261
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
    Kontoghiorghes GJ, Sheppard L, Chambers S.
    Arzneimittelforschung; 1987 Oct 01; 37(10):1099-102. PubMed ID: 3435580
    [Abstract] [Full Text] [Related]

  • 28. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    Barradas MA, Jeremy JY, Kontoghiorghes GJ, Mikhailidis DP, Hoffbrand AV, Dandona P.
    FEBS Lett; 1989 Mar 13; 245(1-2):105-9. PubMed ID: 2494068
    [Abstract] [Full Text] [Related]

  • 29. Effect of ferrous and ferric chelators on transferrin-iron-macrophage interactions.
    Baynes RD, Friedman BM, Bukofzer GT, Bothwell TH, Macfarlane BJ, Lamparelli RD.
    Am J Hematol; 1988 Sep 13; 29(1):27-32. PubMed ID: 3177366
    [Abstract] [Full Text] [Related]

  • 30. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG, Randell EW, Olivieri NF, Templeton DM.
    Biochim Biophys Acta; 1995 Apr 13; 1243(3):373-80. PubMed ID: 7727512
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.
    Molenda JJ, Basinger MA, Hanusa TP, Jones MM.
    J Inorg Biochem; 1994 Aug 01; 55(2):131-46. PubMed ID: 8051541
    [Abstract] [Full Text] [Related]

  • 33. Effect of iron chelation on the in-vitro growth of Leishmania promastigotes.
    Soteriadou K, Papavassiliou P, Voyiatzaki C, Boelaert J.
    J Antimicrob Chemother; 1995 Jan 01; 35(1):23-9. PubMed ID: 7768775
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma.
    Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S.
    Med Chem; 2007 Sep 01; 3(5):469-74. PubMed ID: 17897073
    [Abstract] [Full Text] [Related]

  • 36. New orally active iron chelators.
    Kontoghiorghes GJ.
    Lancet; 1985 Apr 06; 1(8432):817. PubMed ID: 2858689
    [No Abstract] [Full Text] [Related]

  • 37. Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).
    Fernández-Martín JL, Menéndez-Fraga P, Canteros MA, Díaz-López JB, Cannata-Andía JB.
    Clin Chim Acta; 1994 Oct 31; 230(2):137-45. PubMed ID: 7834865
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells.
    Link G, Konijn AM, Hershko C.
    J Lab Clin Med; 1999 Feb 31; 133(2):179-88. PubMed ID: 9989770
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.